Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/23723556.2016.1227894 http://scihub22266oqcxt.onion/10.1080/23723556.2016.1227894 C5160400!5160400!28090577     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Cell+Oncol 2016 ; 3 (6): ä Nephropedia Template TP {{tp|p=28090577|t=2016. Modeling intratumor heterogeneity through CRISPR-barcodes |pdf=|usr=}}{{28090577}} gab.com Text Modeling intratumor heterogeneity through CRISPR-barcodes JO: Mol Cell Oncol http://www.kidney.de/pget.php?&tw=1&pmid=28090577 #FOAvip We have devised a barcoding strategy to recapitulate cancer evolution through the emergence of subclonal mutations of interest, whose effects can be monitored in a dynamic manner. This approach can be easily adapted for a variety of applications, including combined modeling of multiple mechanisms of drug resistance or repair of oncogenic driver mutations in addicted cancer cells. Twit Text FOAVip Modeling intratumor heterogeneity through CRISPR-barcodes ????Mol Cell Oncol http://www.kidney.de/pget.php?&tw=1&pmid=28090577 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28090577 #FOAvip English Wikipedia <ref>{{Cite pmid|28090577}}</ref> Modeling intratumor heterogeneity through CRISPR-barcodes #MMPMID28090577 Guernet A; Aaronson SA; Anouar Y; Grumolato L Mol Cell Oncol 2016[]; 3 (6): ä PMID28090577show ga We have devised a barcoding strategy to recapitulate cancer evolution through the emergence of subclonal mutations of interest, whose effects can be monitored in a dynamic manner. This approach can be easily adapted for a variety of applications, including combined modeling of multiple mechanisms of drug resistance or repair of oncogenic driver mutations in addicted cancer cells. äModeling intratumor heterogeneity through CRISPR-barcodes (epmc).pdf DeepDyve Pubget Overpricing